大型药企聚焦千亿神经药物市场,高额并购不断

制药网
31 Jul

【制药网 行业动态】随着市场需求的不断增长,全球神经科学药物市场规模也在持续扩大。业内预计,该市场将从2022年的1600亿美元增长到2028年的2200亿美元。庞大的市场规模,使精神类药物市场开始成为全球药企新的竞争焦点,同时也带起了该赛道的风口。近日,有报道显示,艾伯维正在洽谈收购专注于精神健康治疗的Gilgamesh Pharmaceuticals,这笔潜在交易会对未上市的Gilgamesh...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10